CDC supplement year 2
CDC 补充第 2 年
基本信息
- 批准号:10828080
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAdmission activityAdverse effectsAdverse eventAffectAmericanBiological MarkersCaringCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsChronologyClinicalClinical DataClinical ManagementCollaborationsCommerceCritical CareDataDiagnosisDisease OutbreaksDisparityDoseDrug abuseEmergency CareEmergency Department evaluationEmergency Department patientEmergency department visitEnrollmentEpidemicEpidemiologyEvaluationForensic MedicineHealthHeroinHospitalsIncidenceIngestionKnowledgeLength of StayLiquid ChromatographyMechanical ventilationMedicalMolecularMorphineNaloxoneNational Institute of Drug AbuseOpioidOutcomeOverdosePatient Self-ReportPatientsPatternPeriodicalsPharmaceutical PreparationsPoisonPopulationPrevalencePrincipal InvestigatorPropertyProspective, cohort studyPublic HealthQualifyingReportingResearchResearch ActivityResearch PersonnelResource AllocationResourcesRisk FactorsSamplingSeveritiesStandardizationSystemTestingTimeTime trendToxicologyTreatment ProtocolsVisitabuse liabilityaddictionanalytic epidemiologyclinical effectclinical predictorsclinical riskcohortcostdesigndrug of abusefentanyl analogfentanyl overdoseheroin overdoseillicit opioidimprovedinsightmultidisciplinarynovelopioid epidemicopioid overdoseopioid useorgan injuryoverdose deathpatient registryprescription opioidprospectiveregional differencescreeningsedativesexstemsubstance usesynthetic opioidtandem mass spectrometrytime of flight mass spectrometrytrendtrend analysis
项目摘要
ABSTRACT AND PROJECT SUMMARY
The purpose of this R01 proposal is to deepen our knowledge of the primary cause of drug overdose deaths in
the U.S. today: novel psychoactive synthetic opioids, the majority of which are fentanyl analogues. Using a
nationwide registry of patients who present to emergency departments, novel fentanyl analogue overdose will
be studied in terms of its epidemiology, analytical confirmation, clinical risk factors, and treatment needs, by a
uniquely qualified multidisciplinary team with an extensive track record of collaboration in the field.
The scope of the U.S. opioid epidemic is broadening, with drug overdose deaths nearly tripling from 1999-
2015. For the first time ever, in 2015 U.S. drug overdose deaths surpassed 50,000 (52,404), of which 33,091
(63.1%) involved an opioid. Overdose deaths continued to increase in 2016 to 63,600. Opioid overdoses cost
Americans $504 billion in 2015 (2.8% of gross domestic product), up from six times the prior estimates in 2013.
There was a 27% increase in nationwide Emergency Department visits for opioid overdoses last year alone.
Strategies to mitigate this trend by decreasing the availability and abuse potential of prescription opioids have
been followed by an increase in illicit opioid use. While initially the predominance of illicit opioid overdoses
were a result of heroin exposure, the changing face of global drug commerce introduced synthetic opioid
fentanyl analogues into the drug supply, where they are now estimated to have surpassed heroin as the
primary cause of drug overdose deaths.
Using nearly 70 hospital centers nationwide with bedside evaluation of patients, over 10,000 overdose patients
have been enrolled in the Principal Investigator’s prior study giving this proposal momentum and feasibility.
Our specific aims are four-fold: (1) To derive and validate clinical predictors of adverse health consequences of
fentanyl analogue overdose; (2) To confirm fentanyl analogue exposure via state-of-the-art toxicology testing;
(3) To investigate treatment utilization, duration, and disparities for fentanyl analogue overdose; and (4) To
assess epidemiology of analytically-confirmed fentanyl analogue overdose.
To achieve these Specific Aims, we will prospectively enroll a national sampling of patients. We will implement
the rapid dissemination of alerts and information to the public and public health entities on adverse effects of
fentanyl analogues. At the completion of the proposed research, the field of drug abuse will be significantly
advanced to the benefit of thousands of victims of the U.S. opioid epidemic.
摘要和项目摘要
本 R01 提案的目的是加深我们对药物过量死亡主要原因的了解
今日美国:新型精神活性合成阿片类药物,其中大部分是芬太尼类似物。使用
全国范围内到急诊科就诊的患者登记处发现,新型芬太尼类似物过量服用将
由流行病学、分析确认、临床危险因素和治疗需求等方面进行研究
独特的合格多学科团队,在该领域拥有广泛的合作记录。
美国阿片类药物流行的范围正在扩大,药物过量死亡人数比 1999 年几乎增加了两倍
2015 年。2015 年,美国药物过量死亡人数首次超过 50,000 人(52,404 人),其中 33,091 人
(63.1%) 涉及阿片类药物。 2016 年,服药过量死亡人数继续增加,达到 63,600 人。阿片类药物过量的费用
2015 年美国人的收入为 5,040 亿美元(占国内生产总值的 2.8%),比 2013 年之前估计的六倍高。
仅去年一年,全国范围内因阿片类药物过量而到急诊室就诊的人数就增加了 27%。
通过减少处方阿片类药物的供应和滥用潜力来缓解这一趋势的策略已经
随后非法阿片类药物的使用有所增加。虽然最初非法阿片类药物过量占主导地位
由于接触海洛因,全球毒品贸易的面貌发生了变化,引入了合成阿片类药物
芬太尼类似物进入毒品供应,目前估计它们已超过海洛因,成为
药物过量死亡的主要原因。
利用全国近70个医院中心对患者进行床边评估,超过10,000名过量用药患者
已参加首席研究员之前的研究,为该提案提供了动力和可行性。
我们的具体目标有四个:(1) 推导并验证不良健康后果的临床预测因素
芬太尼类似物过量; (2) 通过最先进的毒理学测试确认芬太尼类似物的暴露;
(3) 调查芬太尼类似物过量的治疗利用率、持续时间和差异; (4) 至
评估经分析证实的芬太尼类似物过量的流行病学。
为了实现这些具体目标,我们将前瞻性地招募全国患者样本。我们将实施
向公众和公共卫生实体快速传播有关不良影响的警报和信息
芬太尼类似物。拟议研究完成后,药物滥用领域将得到显着改善
造福于美国阿片类药物流行病的数千名受害者。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients.
在急诊科患者中,纳洛酮在新型有效阿片类药物和芬太尼过量中使用。
- DOI:10.1001/jamanetworkopen.2023.31264
- 发表时间:2023-08-01
- 期刊:
- 影响因子:13.8
- 作者:Amaducci, Alexandra;Aldy, Kim;Campleman, Sharan L.;Li, Shao;Meyn, Alison;Abston, Stephanie;Culbreth, Rachel E.;Krotulski, Alex;Logan, Barry;Wax, Paul;Brent, Jeffrey;Manini, Alex F.
- 通讯作者:Manini, Alex F.
Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose.
- DOI:10.1080/15563650.2022.2084406
- 发表时间:2022-09
- 期刊:
- 影响因子:3.3
- 作者:Calello, Diane P.;Aldy, Kim;Jefri, Mohamed;Nguyen, Tuyet-Anh T.;Krotulski, Alex;Logan, Barry;Brent, Jeffrey;Wax, Paul;Walton, Sara;Manini, Alex F.
- 通讯作者:Manini, Alex F.
Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.
- DOI:10.1080/10826084.2020.1791184
- 发表时间:2020
- 期刊:
- 影响因子:2
- 作者:Schimmel J;Manini AF
- 通讯作者:Manini AF
Notes from the Field: Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose - Four States, October 6, 2020-March 9, 2021.
- DOI:10.15585/mmwr.mm7034a4
- 发表时间:2021-08-27
- 期刊:
- 影响因子:0
- 作者:Aldy K;Mustaquim D;Campleman S;Meyn A;Abston S;Krotulski A;Logan B;Gladden MR;Hughes A;Amaducci A;Shulman J;Schwarz E;Wax P;Brent J;Manini A;Toxicology Investigators Consortium Fentalog Study Group
- 通讯作者:Toxicology Investigators Consortium Fentalog Study Group
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex Francis Manini其他文献
Alex Francis Manini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex Francis Manini', 18)}}的其他基金
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量的医疗后果
- 批准号:
10160611 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量的医疗后果
- 批准号:
10343784 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量的医疗后果
- 批准号:
10548822 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量服用的医疗后果
- 批准号:
9973939 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量服用的医疗后果
- 批准号:
10546762 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Prevention of the cardiovascular medical consequences of drug overdose
预防药物过量造成的心血管医学后果
- 批准号:
9321939 - 财政年份:2014
- 资助金额:
$ 50万 - 项目类别:
Prevention of the cardiovascular medical consequences of drug overdose
预防药物过量造成的心血管医学后果
- 批准号:
9034300 - 财政年份:2014
- 资助金额:
$ 50万 - 项目类别:
Prevention of the cardiovascular medical consequences of drug overdose
预防药物过量造成的心血管医学后果
- 批准号:
8925040 - 财政年份:2014
- 资助金额:
$ 50万 - 项目类别:
Predicting Adverse Cardiovascular Events in Emergencies Due to Drug Overdose
预测因药物过量导致的紧急情况下的不良心血管事件
- 批准号:
7809615 - 财政年份:2009
- 资助金额:
$ 50万 - 项目类别:
Predicting Adverse Cardiovascular Events in Emergencies Due to Drug Overdose
预测因药物过量导致的紧急情况下的不良心血管事件
- 批准号:
8260540 - 财政年份:2009
- 资助金额:
$ 50万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Research Grant














{{item.name}}会员




